Autolus Therapeutics

NASDAQ: AUTL · Real-Time Price · USD
1.73
-0.12 (-6.49%)
At close: Aug 15, 2025, 3:59 PM
1.76
1.73%
After-hours: Aug 15, 2025, 07:55 PM EDT

Autolus Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-2.72 -5.38 -1.21 -2.63
PEG Ratio
0.10 0.23 0.06 0.09
PS Ratio
59.25 659.71 29.14 160.56
PB Ratio
1.40 10.05 0.60 1.19
P/FCF Ratio
-2.49 -7.15 -1.47 -2.95
P/OCF Ratio
-2.91 -7.69 -1.61 -3.17
OCF/S Ratio
-20.38 -85.74 -18.13 -50.58
Debt / Equity Ratio
0.12 0.48 0.08 0.07
Quick Ratio
10.81 6.15 8.88 11.80
Current Ratio
10.88 6.15 9.18 12.15
Asset Turnover
0.01 0.00 0.01 0.01
Interest Coverage
-25.98 -4.33 -18.39 -148.6
Return on Equity
-0.52 -1.87 -0.5 -0.45
Return on Assets
-0.28 -0.56 -0.3 -0.35
Return on Invested Capital
-0.34 -0.58 -0.31 -0.37
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
-0.13 -2.87 -21.15 -54.22
Net Profit Margin
-21.8 -122.72 -24.03 -60.99
Pretax Profit Margin
-21.65 -122.73 -27.96 -71.24
Operating Profit Margin
-23.86 -114.86 -26.44 -70.48
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-18.03 -92.33 -21.88 -56.65